Management of antimicrobial resistance in animals in Belgium : Measures in veterinary medicine in the One Health context

Similar documents
Activities and achievements related to the reduction in antibiotics use and resistance in veterinary medicine in Belgium in 2016

Activities and achievements regarding the reduction in the use of antibiotics and antimicrobial resistance in veterinary medicine in Belgium in 2017

OIE Resolution and activities related to the Global Action Plan. Regional Seminar for OIE National Focal Points for Veterinary Products 4 th Cycle

GOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY

OIE AMR Strategy, One Health concept and Tripartite activities

OIE Strategy on Antimicrobial Resistance and the need for new diagnostic tools

Council of the European Union Brussels, 13 June 2016 (OR. en)

Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

Control and monitoring of the use of antibiotics as a strategy against antimicrobials resistance

EU strategy to fight against Antimicrobial Resistance

National Action Plan development support tools

OIE strategy on AMR and the Prudent Use of Antimicrobials

Recommendations of the 3 rd OIE Global Conference on Animal Welfare

OIE PVS Pathway including Veterinary Education

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

All medicinal products (for human and veterinary use) are regulated under the single Pharmaceutical Act.

OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials in Animals Part I

Overview of the OIE PVS Pathway

Veterinary Legislation and Animal Welfare. Tania Dennison and David M. Sherman

Role and responsibilities of the veterinarian in the aquatic sector The OIE perspective

OIE standards on the Quality of Veterinary Services

Antimicrobial resistance: the challenges for animal health

Dr Mária Szabó Science and NewTechnologies Departement OIE AMR Strategy and the Prudent Use of Antimicrobials

Antimicrobial Resistance, yes we care! The European Joint Action

RUMA: Advocating Prudent Use of Antimicrobial Compounds

Managing AMR at the Human-Animal Interface. OIE Contributions to the AMR Global Action Plan

Science Based Standards In A Changing World Canberra, Australia November 12 14, 2014

2017 EU Action Plan against AMR state of play of implementation One-Health Network on AMR 26 October Brussels

Antimicrobial Use and Antimicrobial Resistance a strategy for animal agriculture Forum 2014

Combating Antimicrobial Resistance: A Manufacturing Perspective

Request for advice on the impact on public health and animal health of the use of antibiotics in animals

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

The OIE activities to protect animal and human health: Potential contributions in the fight against counterfeit drugs

Pan-Canadian Action Plan on Antimicrobial Resistance and Antimicrobial Use

NAP on AMR: Singapore

Antimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016

Southern and Estaern Title

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

Investing in Human Resources in Veterinary Services

The role of FAO in AMR

World Organisation for Animal Health

Country Report on National Stray Dogs situation Report from Republic of Serbia

Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8

EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA

MIDDLE EAST REGIONAL ANIMAL WELFARE STRATEGY

Consultation on a draft Global action plan to address antimicrobial resistance

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

The impact of Good Veterinary Services Governance (GVSG) on the control over Veterinary Medicinal Products (VMP s)

Evaluation of Performance of Veterinary Services - Viet Nam experience

Antimicrobial resistance (AMR): action plans implementation. Kamil Saytkulov February, Moscow

Pan-Canadian Framework and Approach to Antimicrobial Resistance. Presentation to the TATFAR Policy Dialogue September 27, 2017

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)

CHALLENGES AND COLLABORATION

German Antimicrobial Resistance Strategy DART 2020

Key elements to organise a mass dog vaccination campaign

The Philippine Action Plan to Combat Antimicrobial Resistance: One Health Approach

Comments of Consumer Reports on Draft Recommendations of the Ad Hoc Interagency Coordination Group on Antimicrobial Resistance

Collection of quantitative data on the use of antimicrobial agents including the establishment of an OIE database

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

Action and Experience of Containment of AMR in Veterinary Sector JAPAN

Antimicrobial resistance. Summary of OIE Activities

Building Competence and Confidence. The OIE PVS Pathway

RECENT ACTIVITIES OF THE NATIONAL FOCAL POINT FOR VETERINARY PRODUCTS - SWAZILAND PRESENTATION TO

OIE mission in the framework of One Health Focus on antimicrobial resistance (AMR)

International Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals

HMA-V Action plan on antimicrobial issues Version for publication (27 January 2011)

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

OIE s global commitment on fighting animal diseases

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

Animal Welfare: the role of the OIE

Promoting One Health : the international perspective OIE

international news RECOMMENDATIONS

Antimicrobial Resistance Direction Statement for Animals and Plants, and Work Programme

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

Collection of quantitative data on the use of antimicrobial agents including the establishment of an OIE database

World Organisation for Animal Health (OIE) Sub-Regional Representation for Southern Africa

Support for OIE Member Countries OIE PVS / Gap Analysis, Reference Laboratories and twinning programmes

Dr. Gérard Moulin AFSSA/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE

Speaking notes submitted by Dr. Duane Landals. on behalf of the Canadian Veterinary Medical Association (CVMA)

Consultation on a draft Global action plan to address antimicrobial resistance

UNDERSTANDING SOUTH AFRICA'S CONSUMPTION OF ANTIMICROBIALS

OIE Strategy for Veterinary Products and Terms of Reference for the OIE National Focal Points

The Dutch Model (of controlling antibiotic use in animals)

OIE List of Antimicrobial Agents of Veterinary Importance and OIE Standards and Activities

OIE Standards on Animal Welfare, and Capacity Building Tools and Activities to Support their Implementation

European Medicines Agency role and experience on antimicrobial resistance

Antimicrobial Use and Antimicrobial Resistance in Relation to the Canadian Pork Sector Presented by Jorge Correa Pork Committee Banff May 2013

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance

DR. BASHIRU BOI KIKIMOTO

BPC Antibiotic Stewardship Report

Sales survey of veterinary medicinal products containing antimicrobials in France in Annual report

The promise of aquaculture and the challenge of antimicrobial use

The use of antimicrobials in livestock production and antimicrobial resistance in pathogens from livestock

Dr A T Sigobodhla. Regional Workshop for OIE National Focal Points for Veterinary Products (Cycle V): Ezulwini, Swaziland, 6-8 December 2017

Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector

Antimicrobial stewardship in Canadian agriculture and veterinary medicine. Perspectives from the Ad-Hoc Committee

Action Plan Goal 2 Surveillance and Monitoring Strategies:

Evaluation of EU strategy to combat AMR

Transcription:

Management of antimicrobial resistance in animals in Belgium : Measures in veterinary medicine in the One Health context ECVPH - Liège, 4th October 2017 Dr. Jean-François HEYMANS DVM, Director Animal Health and Safety of Animal Products. Chief Veterinary Officer (CVO) Belgian Delegate to the OIE

Table of contents 1. Introduction 2. Belgian background 3. 2016 - Pivotal year 1. Convention stakeholders - authorities 2. New legislation veterinary drugs 4. Results 2016 5. Future 2

FASFC Federal Agency for the Safety of The Food Chain ( Operational standards + Controls) Service structures (Authority) and place of AMCRA Federal Ministers of Agriculture and Public Health FPS Public Health Food Chain Safety and Environment (Standards) Federal Agency for medicines (Standards + Controls) Non-profit organization 3

1. Introduction Priority of world public health addressed in the One Health context 4

1. Introduction Priority of a European public health addressed in the context of One Health 5

1. Introduction Priority of public health in Belgium addressed in the context One Health Priority of the Belgian Government, the Administrations and the Sectors concerned. Set up 'the enrolment of the sectors for an effective implementation of recommendations and rules From autoregulation to co-regulation (2016). Approach One Health What to do together? 6

1. Introduction Link Resistances - used quantities of Abios Major axis = decrease the used quantities 7

1. Introduction Public Health Human medicine Causes - Consequences - Solutions Animal Health Veterinary medicine Environmental Economical and Soci(et)al 8

Table of contents 1. Introduction 2. Belgian background 3. 2016 - Pivotal year 1. Convention stakeholders - Authorities 2. New legislation veterinary drugs 4. Results 2016 5. Future 9

2. Belgian background 1999 : Creation of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). 10

2. Belgian background 2011 : First Key year - the collective awareness (Authorities - Sectors) Source: Belvetsac 2012 : The reaction: Setting up of the AMCRA non-profit oganization AntiMicrobial Consumption and Resistance in Animals Authorities + sectors (Vets+Agri+Pharma+feed) => actions and financing Sustainable use of antibiotics (reduce use and resistances) Gather information - Analyse - Advise - Communicate 11

2. Belgian background 12

2. Belgian background First encouraging results 13

Table of contents 1. Introduction 2. Belgian background 3. 2016 - Pivotal year 1. Convention stakeholders - Authorities 2. New legislation veterinary drugs 4. Results 2016 5. Future 14

3. 2016 - Pivotal year 2016 : Pivotal year (= 2d Key year) - The need to go further faster From autoregulation to co-regulation An agreement convention between Authorities & stakeholders on common goals and leading actions A new legislation 15

3. 2016 - Pivotal year 2016 : Pivotal year - The need to go further faster 16

3. 2016 - Pivotal year Convention stakeholders - Authorities Goals: 1. Gather Human + Veterinary Authorities & the stakeholders around objectives of common quantifiable goals of decrease 2. Define the role, the actions and the commitments of everyone to reach that goal 17

3. 2016 - Pivotal year Convention stakeholders - Authorities Who: Political authorities: Fed. Min. De Block (Public Health) and Borsus (Agriculture) => Signatories Administrative bodies: FASFC, FAMHP AMCRA (including coordination) Fed. professional agricultural organizations (FWA, BB, ABS), veterinarians (UPV, VDV), pharmaceutical industry (Pharma.be), feed manufacturer (Bemefa-Apfaca) Managers of specifications First-line laboratories: ARSIA/DGZ => Authorities + 16 organizations 18

3. 2016 - Pivotal year Convention stakeholders - Authorities Strategic goals: Reductions of (based upon reference 2011) 50 % of use of antibiotics in general until end 2020, 75 % of use of the most critical antibiotics (third- and fourth-generation fluoroquinolones and cephalosporins) from now until end 2020, 50 % of use of medicated feed containing antibiotics for end 2017. Operational goals - tools Measure Decrease via regulatory pathway Everyone acts at their own level 19

3. 2016 - Pivotal year New legislation veterinary drugs 20

3. 2016 - Pivotal year New legislation veterinary drugs - 2016 3 Parts: 1. Administrative - veterinary drugs (veterinaries and breeders) = modernisation legislation 2000 2. Conditions of use of critical antibiotics 3. Compulsory system of collection of data use of antibiotics Fight against AMR 21

3. 2016 - Pivotal year Part 2: Use of critical antibiotics General rule: prohibition of use Preventive: ban without exceptions Metaphylactic & curative: derogation under conditions 1. Clinical examination on-the-spot of VT 2. Bacterial causes 3. Appropriate sampling or requested autopsy 4. Identification of the bacterial strain based on the samples 5. Standardized sensitivity lab test of AB: min. 7 non critical AB (min. 5 different classes) + critical AB 6. Only efficient AB = critical AB 22

3. 2016 - Pivotal year Part 3: Compulsory system of data collection of antibiotics use Central data base Authority 23

Part 3: System of data collection of antibiotics use: Goals: General use Reporting of veterinarian and breeder of his own data => Benchmarking 24

Table of contents 1. Introduction 2. Belgian background 3. 2016 - pivotal year 1. Convention stakeholders - Authorities 2. New legislation veterinary drugs 4. Results 2016 5. Future 25

4. Results 2016 Global use 2015-2016 - 4.8 % Since 2011: - 20 % 26

4. Results 2016 Antibiotics of critical importance 2015-2016 - 53 % Since 2011: - 56.1 % 27

4. Results 2016 Medicated feed 2015-2016 - 29 % Since 2011: - 38.2 % 28

4. Results 2016 Evolution of bacterial resistances of antibiotics 29

Table of contents 1. Introduction 2. Belgian background 3. 2016 - pivotal year 1. Convention stakeholders - authorities 2. New legislation veterinary drugs 4. Results 2016 5. Future 30

5. The future Measure the use of antibiotics and the AMR Analyse/Evaluate Use Reduction goal Resistances Actions adapted 31

Thank you for your attention! Dr. Jean-François HEYMANS DVM, Director Animal Health and Safety of Animal Products. Chief Veterinary Officer (CVO) Belgian Delegate to the OIE 32